Clinical Trial Update: Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment [NA]

View source ↗

Summary

This clinical trial update analyzes how 18-FDG uptake changes over time in patients with stage III/IV non-small cell lung cancer treated with first-line pembrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Non Small Cell Lung Cancer | NA | Status: COMPLETED